The golden era of ocular disease gene discovery: Race to the finish

Clinical Genetics

Volumn 84, Issue 2, 2013, Pages 99-101

  Swaroop, A ^a   Sieving, P A ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Clinical management; Genetics; Next generation sequencing; Ocular disease; Therapies; Vision

Indexed keywords

EYE DISEASE; GENE; GENE SEQUENCE; GENE THERAPY; GENETICS; HUMAN; LEBER CONGENITAL AMAUROSIS; NOTE; PRIORITY JOURNAL; VISUAL DISORDER;

CLINICAL MANAGEMENT; GENETICS; NEXT-GENERATION SEQUENCING; OCULAR DISEASE; THERAPIES; VISION;

EYE DISEASES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS;

EID: 84880176751     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12204     Document Type: Note

References (31)

1. Bhattacharya SS, Wright AF, Clayton JF et al. Close genetic linkage between X-linked retinitis pigmentosa and a restriction fragment length polymorphism identified by recombinant DNA probe L1.28. Nature 1984: 309: 253-255.
2. Francke U, Ochs HD, de Martinville B et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet 1985: 37: 250-267.
3. Friend SH, Bernards R, Rogelj S et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986: 323: 643-646.
4. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987: 235: 1394-1399.
5. Nathans J, Thomas D, Hogness DS. Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. Science 1986: 232: 193-202.
6. Blanton SH, Cottingham AW, Giesenschlag N, Heckenlively JR, Humphries P, Daiger SP. Further evidence of exclusion of linkage between type II autosomal dominant retinitis pigmentosa (ADRP) and D3S47 on 3q. Genomics 1990: 8: 179-181.
7. Dryja TP, McGee TL, Reichel E et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990: 343: 364-366.
8. Friedman TB, Schultz JM, Ahmed ZM, Tsilou ET, Brewer CC. Usher syndrome: hearing loss with vision loss. Adv Otorhinolaryngol 2011: 70: 56-65.
9. Novarino G, Akizu N, Gleeson JG. Modeling human disease in humans: the ciliopathies. Cell 2011: 147: 70-79.
10. Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005: 308: 385-389.
11. Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005: 308: 419-421.
12. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005: 308: 421-424.
13. Zareparsi S, Branham KE, Li M et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 2005: 77: 149-153.
14. Hageman GS, Anderson DH, Johnson LV et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005: 102: 7227-7232.
15. Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA 2001: 285: 540-544.
16. International HapMap Consortium. The International HapMap Project. Nature 2003: 426: 789-796.
17. Chen W, Stambolian D, Edwards AO et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 2010: 107: 7401-7406.
18. AMD Gene Consortium. Seven new loci associated with age-related macular degeneration. Nat Genet 2013: 45: 433-439.
19. Neale BM, Fagerness J, Reynolds R et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 2010: 107: 7395-7400.
20. Mardis ER. Next-generation sequencing platforms. Annu Rev Anal Chem 2013: Apr 1. [Epub ahead of print]. PMID: 23560931.
21. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet 2010: 11: 31-46.
22. Hawkins RD, Hon GC, Ren B. Next-generation genomics: an integrative approach. Nat Rev Genet 2010: 11: 476-486.
23. Gargis AS, Kalman L, Berry MW et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol 2012: 30: 1033-1036.
24. Wong KM, Hudson TJ, McPherson JD. Unraveling the genetics of cancer: genome sequencing and beyond. Annu Rev Genomics Hum Genet 2011: 12: 407-430.
25. Katsanis SH, Katsanis N. Molecular genetic testing and the future of clinical genomics. Nat Rev Genet 2013: 14: 415-426.
26. Cooper GM, Shendure J. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat Rev Genet 2011: 12: 628-640.
27. Maguire AM, Simonelli F, Pierce EA et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008: 358: 2240-2248.
28. Bainbridge JW, Smith AJ, Barker SS et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008: 358: 2231-2239.
29. Hauswirth WW, Aleman TS, Kaushal S et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 2008: 19: 979-990.
30. Jacobson SG, Cideciyan AV, Ratnakaram R et al. Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 2012: 130: 9-24.
31. Cideciyan AV, Jacobson SG, Beltran WA et al. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci USA 2013: 110: E517-E525.